PRTO - Proteon Therapeutics Tue 24'th Jan 2017
Stock analysis for Tue 24'th Jan 2017 (Updated daily)
Hold candidate since 2017-01-24
Proteon Therapeutics Stock Analysis
No changes to the price of Proteon Therapeutics in the last trading day. The price has risen in 5 of the last 10 days days and is up by 2.5% over the past 2 weeks.
Proteon Therapeutics lies in the middle of a very wide and strong falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -69.0% during the next 3 months and, with 90% probability hold a price between USD -0.64 and USD 1.50 at the end of this period.
A buy signal was issued from a pivot bottom point on Wednesday January 18, 2017, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Proteon Therapeutics holds a buysignal from the short-term moving average; at the same time, however, a sales signal from the long-term average. Since the longterm average is above the short-term average there is a general salessignal in the stock. On further gains, the stock will meet resistance from the long-term moving average at USD 3.58. On a fall, the stock will find some support from the short-term average at USD 1.99. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sales signal and strengthen the general signal. Volume fell on the last day without any changes to the price. This doesnâ€™t cause any direct divergence but may be an early warning and a possible "turning point".
Relative Strength Index (RSI)
RSI14 is 57 and the stock is currently not being overbought or oversold
Support & Resistance
Proteon Therapeutics finds support from accumulated volume at USD 1.95, USD 1.90, and USD 1.85. On the upside the stock meets some resistance just above today's level from accumulated volume at USD 2.10, USD 2.15 and USD 2.50.
The stock is about to test the resistance from accumulated volume at USD 2.10 and this may cause the stock to take a minor break or get into a more sideways move for a few days.
In general the stock tends to have controlled movements, but the low liquidity has increased the risk substantially.
Our recommended stoploss: USD 1.97 (-3.90%) ( criteria: risk and position in trend)
Proteon Therapeutics holds several positive signals, but we still don't find these to be enough for a buy-recommendation. At the current level we recommend a hold or accumulate position awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Buy Candidate to a Hold/Accumulate.